Therapeutic potential of alpha-glucosidase-inhibitors.
D020909:Acarbose; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000188:drug therapy; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D004377:Dumping Syndrome / Q000188:drug therapy; D005959:Glucosidases / Q000037:antagonists & inhibitors*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D006951:Hyperlipoproteinemias / Q000188:drug therapy; D008659:Metabolic Diseases / Q000188:drug therapy*; D009765:Obesity / Q000188:drug therapy; D009844:Oligosaccharides / Q000627:therapeutic use*; D010349:Patient Compliance; D014312:Trisaccharides / Q000627:therapeutic use*
D001786:Blood Glucose; D065089:Glycoside Hydrolase Inhibitors; D009844:Oligosaccharides; D014312:Trisaccharides; D005959:Glucosidases; D020909:Acarbose